样式: 排序: IF: - GO 导出 标记为已读
-
Ventriculo‐arterial uncoupling with an impella assisted HVAD: The p‐D LVAD Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-22 Hassan Ashraf, Manish Patel, Ismael Salas De Armas, Marwan Jumean
This paper presents the novel use of a temporary percutaneous ventricular assist device (pVAD) in a 51‐year‐old man with an implanted durable left ventricular assist device (d‐LVAD). The pre‐existing left ventricular assist device was unable to successfully unload the left ventricle, and the addition of the temporary pVAD achieved successful unloading as well as a decrease in pulmonary artery pressures
-
Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Pedro Engel Gonzalez, Samuel Gregerson, Shazil Mahmood, Collin Brooks, Pedro A. Villablanca, Tiberio M. Frisoli, James Lee, Janet F. Wyman, Dee Dee Wang, William W. O'Neill, Brian P. O'Neill
BackgroundThe clinical efficacy and safety of alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy (HCM) have been well‐established; however, less is known about outcomes in patients undergoing preemptive ASA before transcatheter mitral valve replacement (TMVR).AimsThe goal of this study is to characterize the procedural characteristics and examine the clinical outcomes of ASA
-
Single suture‐mediated closure system after transfemoral transcatheter aortic valve implantation: A single‐center real‐world experience Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Fortunato Iacovelli, Osvaldo Burattini, Francesca Sturdà, Mattia Branca, Eugenio Stabile, Luigi Fimiani, Luigi Salemme, Angelo Cioppa, Armando Pucciarelli, Alessandro Cafaro, Alessandro Santo Bortone, Gaetano Contegiacomo, Antonio Pignatelli, Tullio Tesorio
BackgroundDespite the use of two crossed Perclose ProGlide™ (Abbott Vascular Devices) is the most widespread technique to close the main arterial access in transfemoral transcatheter aortic valve implantation (TF‐TAVI), the safest and most effective strategy still remains much debated.AimsThe aim of the present study was to evaluate the performance of a single Perclose ProGlide suture‐mediated closure
-
Prevalence and anatomical factors associated with stent under‐expansion in non‐severely calcified lesions Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Takao Sato, Mitsuaki Matsumura, Kei Yamamoto, Evan Shlofmitz, Jeffrey W. Moses, Omar K. Khalique, Doosup Shin, Ali Dakroub, Mandeep Singh, Sarah Malik, Anna Tsoulios, David J. Cohen, Gary S. Mintz, Richard A. Shlofmitz, Allen Jeremias, Ziad A. Ali, Akiko Maehara
BackgroundStent underexpansion, typically related to lesion calcification, is the strongest predictor of adverse events after percutaneous coronary intervention (PCI). Although uncommon, underexpansion may also occur in non‐severely calcified lesions.AimWe sought to identify the prevalence and anatomical characteristics of underexpansion in non‐severely calcified lesions.MethodsWe included 993 patients
-
Using Ping‐pong technique along with rapid inflate‐deflate ballooning to solve total left main occlusion during transcatheter aortic valve replacement procedure Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Arditya Damarkusuma, Sofian Johar, Billal Patel, Chea Chin Yung
Coronary obstruction during transcatheter aortic valve replacement (TAVR) poses a significant threat, prompting a closer examination of prevention and bailout strategies. Following TAVR deployment with a coronary artery obstruction complication and recognizing the complexities involved in engaging the left main coronary artery through TAVR cells. This case introduces the “Ping‐pong” technique using
-
Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Alessandro Spirito, Michael Gao, Samantha Sartori, Birgit Vogel, Paris Pentousis, Ranbir Singh, Yijia Jiang, George Dangas, Annapoorna Kini, Samin K. Sharma, Roxana Mehran
BackgroundThe number of octogenarians referred to percutaneous coronary interventions (PCI) is rising steadily. The prevalence and prognostic impact of complex PCI (CPCI) in this vulnerable population has not been fully evaluated.MethodsPatients ≥80 years old who underwent PCI between 2012 and 2019 at Mount Sinai Hospital were included. Patients were categorized based on PCI complexity, defined as
-
Successful treatment of severe primary mitral regurgitation due to rheumatic aetiology using a novel‐designed transcatheter edge‐to‐edge repair system Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Chun‐Mei Xie, Da Zhu, Shou‐Zheng Wang, Xiang‐Bin Pan
The transcatheter edge‐to‐edge mitral valve repair (TEER) has been recommended as a reliable treatment option for selected patients with severe degenerative and functional mitral regurgitation (MR). Although MR patients with rheumatic etiology were excluded from two significant trials (EVEREST II and COAPT) that established a role for the TEER in degenerative and functional MR. However, it has been
-
Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Federico Giacobbe, Eduardo Valente, Arianna Morena, Marco Nebiolo, Giuseppe Giannino, Ovidio De Filippo, Francesco Bruno, Elena Isaevska, Lorenzo Richiardi, Mario Iannaccone, Giuseppe Biondi Zoccai, Francesco Burzotta, Fabrizio D'Ascenzo, Gaetano Maria De Ferrari
IntroductionAmong different coronary stents implanted in High Bleeding Risk (HBR) patients with an indication for short antiplatelet therapy, no comparisons in terms of efficacy have been provided.MethodsA Network Meta Analysis was performed including all randomized controlled trials comparing different coronary stents evaluated in HBR patients. Major Adverse Cardiovascular Events (MACEs) as defined
-
Device regulation and surveillance in vascular care: Challenges and opportunities Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Alyssa J. Pyun, Philip P. Goodney, Jens Eldrup‐Jorgensen, James Wadzinski, Eric A. Secemsky, Joaquin E. Cigarroa
Cardiovascular devices are essential for the treatment of cardiovascular diseases including cerebrovascular, coronary, valvular, congenital, peripheral vascular and arrhythmic diseases. The regulation and surveillance of vascular devices in real‐world practice, however, presents challenges during each individual product's life cycle. Four examples illustrate recent challenges and questions regarding
-
Combined transcatheter aortic valve and tricuspid valve‐in‐valve implantation in a patient with a mitral mechanical prosthesis Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-19 Maria Rita Lima, João Brito, Manuel Almeida, Rui Campante Teles
Despite progressively uncommon in Western countries, rheumatic heart disease still portrays a significant global burden. In elderly or high‐surgical risk patients, plurivalvular disease may require a complex percutaneous approach. Transcatheter aortic valve implantation (TAVI) in patients with previous monoleaflet mitral prosthesis is challenging due to interference between the aortic valve and the
-
Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-17 Athanasios Rempakos, Michaella Alexandrou, Deniz Mutlu, James W. Choi, Paul Poommipanit, Jaikirshan J. Khatri, Laura Young, Brian Jefferson, Sevket Gorgulu, Farouc A. Jaffer, Raj Chandwaney, Rhian Davies, Stewart Benton, Khaldoon Alaswad, Lorenzo Azzalini, Kathleen E. Kearney, Oleg Krestyaninov, Dmitrii Khelimskii, Philip Dattilo, Niranjan Reddy, Nidal Abi‐Rafeh, Ahmed Elguindy, Omer Goktekin, Bavana
BackgroundThe complex high‐risk indicated percutaneous coronary intervention (CHIP) score is a tool developed using the British Cardiovascular Intervention Society (BCIS) database to define CHIP cases and predict in‐hospital major adverse cardiac or cerebrovascular events (MACCE).AimTo assess the validity of the CHIP score in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).MethodsWe
-
-
Percutaneous retrieval of an embolized Watchman device on a papillary muscle in the left ventricle Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-12 Mitra M. Patel, Sourabh Prabhakar, Carson Oostra, P. Kasi Ramanathan
The use of left atrial appendage occlusion (LAAO) devices have gained prominence as an alternative to long‐term anticoagulation therapy in patients with atrial fibrillation at risk of stroke and high risk of bleeding. While these devices have shown efficacy in reducing stroke risk, there have been reported cases of embolization of the Watchman device. There are very few cases of successful percutaneous
-
Effect of EDTA with porous balloon on calcified lesion: An atherosclerotic cadaver study Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-12 Kenji Kawai, Anna Madra, Rika Kawakami, Yu Sato, Takao Konishi, Tatsuya Shiraki, Teruo Sekimoto, Takamasa Tanaka, Renu Virmani, Aloke V. Finn
BackgroundEthylene diamine tetra‐acetic acid (EDTA) is a chelating agent used to dissolve calcium deposits but evidence in decalcifying atherosclerotic lesions is limited.AimsWe assessed the feasibility and efficacy of EDTA delivered via porous balloon to target calcified lesions in cadaveric below‐the‐knee (BTK) arteries.MethodsUsing porcine carotid arteries, EDTA concentration was measured in the
-
A novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-12 Brian C. Case, Najdat Bazarbashi, Adam Johnson, Toby Rogers, Itsik Ben‐Dor, Lowell F. Satler, Ron Waksman, Hayder D. Hashim, Robert Gallino, Nelson L. Bernardo
The advent of excimer laser coronary atherectomy (ELCA) nearly four decades ago heralded a novel way to treat complex lesions, both coronary and peripheral, which were previously untraversable and thus untreatable. These complex lesions include heavily calcified lesions, ostial lesions, bifurcation lesions, chronic total occlusions, in‐stent restenosis (including stent underexpansion), and degenerative
-
Finite element modeling with patient‐specific geometry to assess clinical risks of percutaneous pulmonary valve implantation Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-10 Carly L. Donahue, Claire L. Westman, Brittany L. Faanes, Athar M. Qureshi, Victor H. Barocas, Varun Aggarwal
BackgroundPercutaneous pulmonary valve implantation (PPVI) is a non‐surgical treatment for right ventricular outflow tract (RVOT) dysfunction. During PPVI, a stented valve, delivered via catheter, replaces the dysfunctional pulmonary valve. Stent oversizing allows valve anchoring within the RVOT, but overexpansion can intrude on the surrounding structures. Potentially dangerous outcomes include aortic
-
One‐year initial efficacy and safety outcomes of the premounted dry‐pericardium Vienna self‐expandable transcatheter aortic valve system: A first‐in‐human VIVA feasibility study Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-09 Kasparas Briedis, Egle Rumbinaite, Ali Aldujeli, Kamilija Briede, Martynas Jurenas, Povilas Jakuska, Antanas Jankauskas, Indre Ceponiene, Tadas Lenkutis, Jurgita Plisiene, Rimantas Benetis, Remigijus Zaliunas
BackgroundThe dry‐pericardium Vienna transcatheter aortic valve system is repositionable and retrievable, already premounted on the delivery system, eliminating the need for assembly and crimping of the device before valve implantation.MethodsThe VIVA first‐in‐human feasibility study, a prospective, nonrandomized, single‐center trial, evaluated the Vienna aortic valve in 10 patients with severe symptomatic
-
Use of percutaneous mechanical circulatory support for right ventricular failure Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-08 Kartik Gupta, Alejandro Lemor, Ahmad Alkhatib, Patrick McBride, Jennifer Cowger, Gillian Grafton, Khaldoon Alaswad, William O'Neill, Pedro Villablanca, Mir B. Basir
BackgroundUtilization of right ventricular mechanical circulatory support (RV‐MCS) devices has been limited by a lack of recognition of RV failure as well as a lack of availability and experience with RV‐MCS.AimsWe report a single‐center experience with the use of percutaneous RV‐MCS and report predictors of adverse outcomes.MethodsThis was a single‐center retrospective cohort study. Data from consecutive
-
Comparison between the outcomes of transfemoral access and transfemoral access with adjunct upper extremity access in patients undergoing endovascular aortic repair: A pilot systematic review and meta‐analysis Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-08 Aman Goyal, Laveeza Fatima, Fiza Mushtaq, Muhammad Daoud Tariq, Aemen Kamran, Amir Humza Sohail, Zainali Chunawala, Samia Aziz Sulaiman, Abhigan Babu Shrestha, Abu Baker Sheikh, Agastya D. Belur
Endovascular aortic repair is an emerging novel intervention for the management of abdominal aortic aneurysms. It is crucial to compare the effectiveness of different access sites, such as transfemoral access (TFA) and upper extremity access (UEA). An electronic literature search was conducted using PubMed, EMBASE, and Google Scholar databases. The primary endpoint was the incidence of stroke/transient
-
Novel valve‐in‐surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN) Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-08 Cullen E. Buchanan, Mina Iskander, Saif Anwaruddin, Peter J. Mason
An 86‐year‐old female with history of surgical aortic valve replacement presented with clinical signs of heart failure. Echocardiography revealed a reduction in left ventricular systolic function and severe bioprosthetic aortic valve dysfunction. This is the first reported case of valve‐in‐valve transcatheter aortic valve replacement with concomitant undermining iatrogenic coronary obstruction with
-
Mobile bedside ductus arteriosus closure in severely premature neonates using only echocardiographic guidance Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-08 Stanimir Georgiev, Daniel Tanase, Andreas Eicken, Jürgen Hörer, Evan Zahn, Kristina Borgmann, Dunja Renner, Peter Ewert
BackgroundTranscatheter closure of the patent ductus arteriosus (PDA) in premature infants is currently dependent on fluoroscopic guidance and transportation to the catheterization laboratory.AimWe describe a new echocardiographically guided technique to allow our team to move to the bedside at the neonatal intensive care unit (NICU) of the referring center for percutaneous treatment of PDA in premature
-
Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-05 Daniel Tébar, Xavier Carrillo, Bruno García del Blanco, Joan Antoni Gómez‐Hospital, Luis Nombela, Eduardo Molina, Guillermo Galeote, Victoria Vilalta, Vicenc Serra‐García, Guillem Muntané Carol, Santiago Jiménez‐Valero, Eduard Fernandez‐Nofrerias, Álvaro Calabuig‐Goena, Alfonso Jurado‐Román, Ángel Sánchez‐Recalde, María Fernández Velasco, Lisardo Pérez‐Solares, Raúl Moreno
BackgroundPrevious studies have documented a high rate of implantation success with the ACURATE neo2 valve, as well as a reduction in paravalvular leak (PVL) compared to its predecessor, the ACURATE neo. However, there are no studies that have reviewed and compared the long‐term clinical and hemodynamic outcomes of these patients.AimsThis study aimed to evaluate the results of the ACURATE neo transcatheter
-
Transcatheter aortic valve implantation for pure aortic insufficiency in a patient following David‐type aortic valve‐sparing root replacement after aortic dissection—A successful off‐label procedure Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-05 Didem Melis Oztas, Emrah Ozdemir, Robert Bauernschmitt, Murat Ugurlucan
Transcatheter aortic valve implantation (TAVI) has traditionally been indicated for the treatment of aortic stenosis. However, in this case report, we describe a successful TAVI procedure in a 46‐year‐old male patient who had previously undergone David aortic valve‐sparing aortic root replacement for type 1 aortic dissection. The patient presented with aortic valve insufficiency 4 years after the initial
-
Percutaneous mechanical thrombectomy in acute pulmonary embolism: Outcomes from a safety‐net hospital Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-05 Robert S. Zhang, Carlos L. Alviar, Eugene Yuriditsky, Usman Alam, Peter S. Zhang, Lindsay Elbaum, Kelsey Grossman, Arushi Singh, Muhammad H. Maqsood, Allison A. Greco, Radu Postelnicu, Vikramjit Mukherjee, James Horowitz, Norma Keller, Sripal Bangalore
BackgroundOur study aims to present clinical outcomes of mechanical thrombectomy (MT) in a safety‐net hospital.MethodsThis is a retrospective study of intermediate or high‐risk pulmonary embolism (PE) patients who underwent MT between October 2020 and May 2023. The primary outcome was 30‐day mortality.ResultsAmong 61 patients (mean age 57.6 years, 47% women, 57% Black) analyzed, 12 (19.7%) were classified
-
The impact of unilateral pulmonary artery stenosis on right ventricular to pulmonary arterial coupling in patients with transposition of the great arteries Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-05 Renée S. Joosen, Michiel Voskuil, Gregor J. Krings, M. Louis Handoko, Michael G. Dickinson, Marielle C. van de Veerdonk, Johannes M. P. J. Breur
BackgroundUnilateral pulmonary artery (PA) stenosis is common in the transposition of the great arteries (TGA) after arterial switch operation (ASO) but the effects on the right ventricle (RV) remain unclear.AimsTo assess the effects of unilateral PA stenosis on RV afterload and function in pediatric patients with TGA‐ASO.MethodsIn this retrospective study, eight TGA patients with unilateral PA stenosis
-
Three‐year clinical outcomes after transcatheter aortic valve implantation in patients with bicuspid aortic disease: Comparison between self‐expanding and balloon‐expandable valves Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-05 Mauro Boiago, Michele Bellamoli, Chiara De Biase, Alessandro Beneduce, Lola Gutierrez Alonso, Pietro Laforgia, Souehib Feliachi, Omar Alessandro Oliva, Nicolas Dumonteil, Didier Tchétché
IntroductionBicuspid aortic valve (BAV) stenosis is a complex anatomical scenario for transcatheter aortic valve implantation (TAVI). Favorable short‐term clinical outcomes have been reported with TAVI in this setting, but long‐term data are scarce.MethodsWe retrospectively included, in a single‐center registry, patients with BAV stenosis who underwent TAVI before 2020. We compared patients treated
-
Direct versus indirect effects of extracorporeal membrane oxygenation Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-03 Marc L. Dickstein
-
Solid state, pulsed‐wave 355 nm UV laser atherectomy debulking in the treatment of infrainguinal peripheral arterial disease: The Pathfinder Registry Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-03 Tony S. Das, Nicolas W. Shammas, Jason A. Yoho, Pedro Martinez‐Clark, Venkatesh Ramaiah, Luis R. Leon, John P. Pacanowski, Zaheed Tai, Vaqar Ali, Bulent Arslan, John Rundback
BackgroundAtherectomy is an important option for debulking atherosclerotic plaque from diseased arteries in patients with infrainguinal arterial disease. Laser atherectomy uses a high‐powered laser to remove the plaque from the arteries to restore blood flow.AimsThe Pathfinder multicenter registry was initiated to evaluate the safety and efficacy of the 355 nm laser atherectomy system in a real‐world
-
Impact of vessel volume on thermodilution measurements in patients with coronary microvascular dysfunction Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-03 Koshiro Sakai, Tatyana Storozhenko, Takuya Mizukami, Hirofumi Ohashi, Frederic Bouisset, Atomu Tajima, Lieven van Hoe, Emanuele Gallinoro, Giulia Botti, Thabo Mahendiran, Sofie Pardaens, Sofie Brouwers, Samer Fawaz, Thomas R. Keeble, John R. Davies, Jeroen Sonck, Bernard De Bruyne, Carlos Collet
BackgroundTwo invasive methods are available to estimate microvascular resistance: bolus and continuous thermodilution. Comparative studies have revealed a lack of concordance between measurements of microvascular resistance obtained through these techniques.AimsThis study aimed to examine the influence of vessel volume on bolus thermodilution measurements.MethodsWe prospectively included patients
-
A multicenter prospective observational study appraising the effectiveness of the Supera stent after subintimal recanalization of femoro‐popliteal artery occlusion: The SUPERSUB II study Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-03 Luis Mariano Palena, Giacomo Isernia, Gianbattista Parlani, Pierfrancesco Veroux, Ilaria Ficarelli, Arian Frascheri, Aldo Pischedda, Lorenzo Patrone, Carlo Patrizio Dionisi, Roberto Cianni, Flavio Airoldi, Pietro Landino, Andrès Kleiban, Pietro Filauri, Giovanni Passalacqua, Pier Luigi Antignani, Enrico De Rose, Albert Valls, Giuseppe Biondi‐Zoccai, Marco Manzi
BackgroundComplex femoropopliteal artery disease represents a challenge. The Supera stent holds the promise of improving the results of endovascular therapy for complex femoropopliteal disease.AimsWe aimed at appraising the early and long‐term effectiveness of the Supera stent after successful subintimal angioplasty (SuperSUB strategy) for complex femoropopliteal lesions.MethodsWe conducted a multicenter
-
Extent of cardiac damage before transcatheter aortic valve replacement: Beyond aortic stenosis per se Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-02 Ran Kornowski
In a seminal paper, Philippe Genereux1 and colleagues proposed a classification system for myocardial damage in aortic stenosis (AS) before aortic valve replacement (AVR). This classification system categorizes patients with AS into one of five groups based on the extent of myocardial damage as detected by echocardiography before AVR. The five groups are as follows: 1. No extra-valvular cardiac damage
-
Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-02 Ahmed Al‐Ogaili, Michaella Alexandrou, Athanasios Rempakos, Deniz Mutlu, James W. Choi, Paul Poommipanit, Jaikirshan J. Khatri, Khaldoon Alaswad, Mir B. Basir, Raj H. Chandwaney, Sevket Gorgulu, Ahmed M. ElGuindy, Basem Elbarouni, Wissam Jaber, Stephane Rinfret, William Nicholson, Farouc A. Jaffer, Nazif Aygul, Lorenzo Azzalini, Kathleen E. Kearney, Jarrod Frizzell, Rhian Davies, Omer Goktekin, Bavana
BackgroundThere is limited data on retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) via ipsilateral epicardial collaterals (IEC).AimsTo compare the clinical and angiographic characteristics, and outcomes of retrograde CTO PCI via IEC versus other collaterals in a large multicenter registry.MethodsObservational cohort study from the Prospective Global registry for the
-
Concordance between vessel‐specific and vascular territory coronary functional assessment: A comparison of quantitative flow ratio and myocardial perfusion scintigraphy Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-04-01 Luciano de Moura Santos, Carlos M. Campos, Hector Manuel Garcia‐Garcia, Roger Renault Godinho, Maria Antonieta Albanez Medeiros Lopes, Vinícius Bocchino Seleme, Rafael Silva Côrtes, Guilherme de Albuquerque Cavalcanti Mendes, Vitor Emer Egypto Rosa, Neuza Helena Moreira Lopes, Fábio Sândoli de Brito Junior, Alexandre Antônio Cunha Abizaid
BackgroundQuantitative flow ratio (QFR) and myocardial perfusion scintigraphy (MPS) are utilized for assessing coronary artery disease (CAD) significance. We aimed to analyze their concordance and prognostic impact.AimsWe aimed to analyze the concordance between QFR and MPS and their risk stratification.MethodsPatients with invasive coronary angiography and MPS were categorized as concordant if QFR
-
Balloons, sheaths, and complications in balloon atrial septostomy Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-28 Jawad Al‐Kassmy, Nagib Dahdah
-
Balloon rupture during transcatheter aortic valve replacement Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-28 Craig Basman, David Landers, Chad Kliger, Karla Rodriguez‐Barragan, Sung‐Han Yoon, Haroon Faraz, Ankitkumar Patel, Yuriy Dudiy, Mark Anderson, Ryan Kaple
A distinctive complication with balloon‐expandable (BE) THV platforms such as the Edwards Sapien (Edwards Lifescience) is the possibility of balloon rupture during THV deployment. Balloon rupture is a rare occurrence that can result in stroke due to fragment embolism, incomplete THV expansion, and/or vascular injury upon retrieval of the balloon. Careful evaluation of preoperative computed tomography
-
Retrieval of a left appendage device from the left ventricle using a large bore steerable catheter Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-28 Abou‐Bakr Abbadi, Mariama Akodad, Jérôme Horvilleur, Antoinette Neylon
Left atrium appendage closure is a safe and effective therapy for patients with atrial fibrillation and high thromboembolic and hemorrhagic risks. Prosthesis embolization is a potential major complication with an incidence of 0.07%. We report a case of migration of an Amplatzer Amulet (Abbott) device that was successfully retrieved in an innovative way (4).
-
Transcatheter valve‐in‐valve interventions after aortic root replacement: A systematic review Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-27 Massimo Baudo, Besart Cuko, Julien Ternacle, Serge Sicouri, Gianluca Torregrossa, Mathieu Pernot, Olivier Busuttil, Antoine Beurton, Anouk Alaux, Alexandre Ouattara, Stephane Lafitte, Guillaume Bonnet, Lionel Leroux, Carlo De Vincentiis, Louis Labrousse, Basel Ramlawi, Thomas Modine
Structural valve deterioration after aortic root replacement (ARR) surgery may be treated by transcatheter valve‐in‐valve (ViV‐TAVI) intervention. However, several technical challenges and outcomes are not well described. The aim of the present review was to analyze the outcomes of ViV‐TAVI in deteriorated ARR. This review included studies reporting any form of transcatheter valvular intervention in
-
Recurrent hypo‐attenuated leaflet thickening after TAVR: Clinical implications Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-26 Andrew Takla, Kirolus Sourial, Gaurav Sharma
Subclinical bioprosthetic valve thrombosis (BPVT) is a relatively common finding in asymptomatic patients during follow‐up imaging. However, its clinical significance is unclear. Data from registries associate BPVT with elevated valve gradients, thromboembolic complications, recurrence, and valve degeneration. Given the dynamic nature of the disease process, management is challenging. The duration
-
Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with! Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-20 Arturo Giordano, Giuseppe Biondi-Zoccai
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest.
-
-
Residual shunt after patent foramen ovale closure: The devil is in the details! Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2024-03-01 Eirini Beneki, Kyriakos Dimitriadis, Argyro Kalompatsou, Konstantinos Tsioufis, Constantina Aggeli
-
Clinical implication of the Naples prognostic score on transcatheter aortic valve replacement in patients with severe aortic stenosis Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-22 Gökhan Demirci, Serkan Aslan, Ahmet Güner, Ali R. Demir, Yunus E. Erata, İrem Türkmen, Ahmet A. Yalçın, Ali K. Kalkan, Fatih Uzun, Ömer Çelik, Mehmet Ertürk
One of the hallmarks of frailty in patients with severe aortic stenosis (AS) is malnutrition, for which one of the most up-to-date scoring systems is the Naples prognostic score (NPS). This study sought to investigate the predictive role of the NPS in determining mortality in patients undergoing transcatheter aortic valve replacement (TAVR) under long-term follow-up.
-
Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-22 Julius Fischer, Julius Steffen, Tobias Arlart, Magda Haum, Sarah Gschwendtner, Philipp M. Doldi, Konstantinos Rizas, Hans Theiss, Daniel Braun, Martin Orban, Sven Peterß, Jörg Hausleiter, Steffen Massberg, Simon Deseive
Patients undergoing transcatheter aortic valve implantation (TAVI) frequently have coronary artery disease requiring percutaneous coronary intervention (PCI). Usually, PCI and TAVI are performed in two separate procedures and current studies are investigating potential benefits regarding the order. However, the two interventions may also be performed simultaneously, thereby limiting the risk associated
-
Interventional cardiologist perceptions about PCI without surgical backup—Results of an international survey Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-17 Christopher M. Fernandez, Adhir R. Shroff, Mladen I. Vidovich
Percutaneous coronary intervention (PCI) without surgical backup is becoming increasingly common in the United States. Additionally, a recent SCAI expert consensus document has liberalized recommendations for performing PCI without cardiac surgery on site (SOS).
-
Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-14 Ziad Arow, Maayan Konigstein, Hana Vaknin-Assa, Guy Witberg, Michael Jonas, Arthur Kerner, Carlos Cafri, Ronen Rubinshtein, Amit Segev, Ariel Roguin, Melek Ozgu Issever, Mustafa Gabarin, David Pereg, Abid Assali, Edward Koifman
The ridaforolimus-eluting stent (RES) system uses a novel cobalt alloy-based coronary stent with a durable elastomeric polymer eluting ridaforolimus.
-
Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-11 Akito Kawamura, Yasuyuki Egami, Naotaka Okamoto, Shodai Kawanami, Koji Yasumoto, Masaki Tsuda, Yasuharu Matsunaga-Lee, Masamichi Yano, Masami Nishino, Keita Okayama
Debulking devices are necessary to treat severe calcified lesions. OAS has a unique characteristic that the burr moves forward and backward. There are few studies reporting the differences of ablation style between only-antegrade and only-retrograde OAS.
-
Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-09 Nikoloz Shekiladze, Pratik B. Sandesara, Zaheed Tai, Nodar Maisuradze, Wissam Jaber, William Nicholson
This article highlights four unique cases where rotational atherectomy (RA Rotapro, Boston Scientific) was used to cut and retrieve an entrapped coronary guidewire with parts extending into the aorta We discuss the technique and step by step approach to the retrieval procedure.
-
Transcatheter mitral valve replacement with Mi-thos system: First-in-human experience Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-09 Ye Yang, Jinmiao Chen, Lili Dong, Yuntao Lu, Minzhi Lv, Kefang Guo, Ghufran Bagaber, Jian Yang, Chunsheng Wang, Lai Wei
Transcatheter mitral valve replacement (TMVR) has become an alternative for high-risk patients with severe mitral regurgitation (MR). The aim of this study was to evaluate the safety and feasibility of the Mi-thos TMVR system (NewMed Medical) for high-risk patients with severe MR.
-
Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-07 Israel M. Barbash, Yishay Wasserstrum, Magdalena Erlebach, Victor Guetta, Johannes Ziegelmüller, Amit Segev, Paul Fefer, Elad Maor, Rüdiger Lange, Hendrik Ruge
New vascular closure devices (VCD) are being introduced for achieving hemostasis after transcatheter aortic valve implantation (TAVI). However, no safety or efficacy data have been published compared to other contemporary VCD.
-
Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-12-04 Giulio Piedimonte, Lorenzo Azzalini, Luigi Ferrarotto, Riccardo Mangione, Enrico Cerrato, Alfonso Franzè, Francesco Tomassini, Cristina Rolfo, Marco Pavani, Greca Zanda, Corrado Tamburino, Ferdinando Varbella, Alessio La Manna
The J-chronic total occlusion (CTO) channel score can predict guidewire tracking of the collateral channels (CCs), but its efficacy in predicting microcatheter tracking has never been tested in the setting of retrograde CTO-percutaneous coronary intervention (PCI).
-
Balloon-expandable transcatheter heart valves for treatment of aortic valve stenosis in patients with large aortic annuli: Evaluation of deployment balloon overfilling strategies Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-30 Yvonne Schneeberger, Harun Sarwari, Benedikt Köll, Till J. Demal, Oliver D. Bhadra, Ina von der Heide, Laura Hannen, David Grundmann, Lisa Voigtländer, Lara Waldschmidt, Johannes Schirmer, Simon Pecha, Niklas Schofer, Nils Sörensen, Stefan Blankenberg, Hermann Reichenspurner, Lenard Conradi, Moritz Seiffert, Andreas Schaefer
Transcatheter aortic valve implantation (TAVI) using balloon-expandable (BE) transcatheter heart valves (THV) in aortic annuli above 29 mm includes particular procedural steps, mainly involving overfilling of the deployment balloon. Data on overfilling strategies in clinical daily practice is scarce. We herein aimed for a retrospective description of utilized overfilling strategies in those patients
-
Cusp overlap method for self-expanding transcatheter aortic valve replacement Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-27 Talal F. Aljabbary, Ikki Komatsu, Tomoki Ochiai, Stephen E. Fremes, Noman Ali, Lucas Burke, Mark D. Peterson, Neil P. Fam, Harindra C. Wijeysundera, Sam Radhakrishnan
Conduction disturbances and the need for permanent pacemaker (PPM) implantation remains a common complication for transcatheter aortic valve replacement (TAVR), particularly when self-expanding (SE) valves are used.
-
Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-23 Awad I. Javaid, Joel E. Michalek, Aleksandra B. Gruslova, Serene A. Hoskins, Chowdhury H. Ahsan, Marc D. Feldman
Previous studies have compared Impella use to intra-aortic balloon pump (IABP) use in patients with acute myocardial infarction and cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI). Our objective was to compare clinical outcomes in patients with AMI-CS undergoing PCI who received Impella (percutaneous left ventricular assist device) without vasopressors, IABP without vasopressors
-
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-22 Zachary L. Steinberg, Samuel G. Rayner, Peter J. Leary
We present the case of a 28-year-old woman with a history of tricuspid valve endocarditis leading to chronic thromboembolic pulmonary hypertension (CTEPH) with multiple pulmonary artery chronic total occlusions (CTOs) due to septic emboli. Following a multidisciplinary care discussion, the patient was brought forward for balloon pulmonary angioplasty (BPA) with successful revascularization of all chronically
-
Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study) Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-22 Ankush Gupta, Abhinav Shrivastava, Sanya Chhikara, Mamas A. Mamas, Rajesh Vijayvergiya, Ajay Swamy, Nalin K. Mahesh, Navreet Singh, Nitin Bajaj, Balwinder Singh, Daulat Singh Meena, Chandraket Singh
Among the two stent strategies, contemporary evidence favors double kissing crush technique (DKC) for complex unprotected distal left main bifurcation (UdLMB) lesions. However one of the major challenges to these lesions is side branch (SB) restenosis.
-
Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-22 Vitaliy Androshchuk, Omar Chehab, Bernard Prendergast, Ronak Rajani, Tiffany Patterson, Simon Redwood
Vascular complications after percutaneous transfemoral transcatheter aortic valve implantation (TAVI) are associated with adverse clinical outcomes and remain a significant challenge.
-
Effects of atherectomy on major adverse limb events for femoropopliteal interventions: Vascular Quality Initiative registry Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-20 Valery S. Effoe, Mark W. Mewissen, Tanvir K. Bajwa, Jayant Khitha, Louie Kostopoulos, Khawaja A. Ammar, Tonga K. Nfor
Atherectomy use in treatment of femoropopliteal disease has significantly increased despite scant evidence of benefit to long-term clinical outcomes.
-
International survey of chronic total occlusion percutaneous coronary intervention operators Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-20 Bahadir Simsek, Athanasios Rempakos, Spyridon Kostantinis, Michaella Alexandrou, Judit Karacsonyi, Bavana V. Rangan, Olga C. Mastrodemos, Deniz Mutlu, Nidal Abi Rafeh, Khaldoon Alaswad, Alexandre Avran, Lorenzo Azzalini, Ahmed ElGuindy, Mohaned Egred, Omer Goktekin, Sevket Gorgulu, Wissam Jaber, Kathleen E. Kearney, Ajay J. Kirtane, William L. Lombardi, Kambis Mashayekhi, Margaret McEntegart, William
Contemporary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) practice has received limited study.
-
Intravascular ultrasound-guided STAR 2.0: A new technique for chronic total occlusion recanalization Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-20 Roberto Garbo, Mario Iannaccone, Francesco Bruno, Manfredi Arioti
The use of the subintimal space has allowed a massive advancement in the field of chronic total occlusion percutaneous coronary intervention (PCI). The STAR technique is the first of subintimal techniques. Despite a high acute success rate, follow-up results showed unfavorable outcomes with half of the treated patients showing restenosis/reocclusion at 6 months. We present three cases in which a modification
-
Transcatheter correction of sinus venosus defect in a patient with a challenging anatomical configuration: From bench testing to clinical success Catheter. Cardiovasc. Interv. (IF 2.3) Pub Date : 2023-11-17 Clement Batteux, Vlad Ciobotaru, William Arditi, Benoit Decante, Clement Karsenty, Nicolas Combes, Sebastien Hascoet
We report successful transcatheter correction of a sinus venosus defect in a 72-year-old woman with anomalous pulmonary venous return in a challenging anatomical configuration. The procedure was facilitated by hands-on simulation training on a newly developed, perfused, 3D-printed model.